Placeholder text

Go to cart

Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers

By Mukesh Nandave

Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers Medicine

Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers

0 - Default Title
Description
This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine.
Product details
Binding:
Paperback
Number of Pages:
616
Release Date:
2025-10-27
Publication Date:
2025-10-27
Publisher:
Springer
Languages:
Original: English
ISBN10:
9819773822
ISBN13:
9789819773824
GPSR Manufacturer Reference:
[email protected]
Weight:
920 g
Height:
155 cm
Width:
235 cm
Thickness:
33 cm
Buy on Amazon
Currently sold out